12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
During Tuesday's pre-market session, several health care stocks experienced significant movement. IMAC Hldgs, Myomo, Ra Medical Systems, Alvotech, Ensysce Biosciences, and ABVC BioPharma saw increases, while Infinity Pharmaceuticals, Laboratory Corp, Bluejay Diagnostics, Aptevo Therapeutics, Lipella Pharmaceuticals, and Kintara Therapeutics experienced decreases.
July 04, 2023 | 1:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ABVC BioPharma stock increased by 11.64% to $0.58.
The significant increase in ABVC BioPharma's share price could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Alvotech shares moved upwards by 17.31% to $9.08.
The significant increase in Alvotech's share price could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
IMAC Hldgs shares increased by 54.5% to $0.17 during Tuesday's pre-market session.
The significant increase in IMAC Hldgs' share price could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Ensysce Biosciences stock increased by 14.44% to $2.06.
The significant increase in Ensysce Biosciences' share price could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Myomo stock moved upwards by 20.81% to $0.63.
The significant increase in Myomo's share price could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Ra Medical Systems shares rose 18.47% to $1.09.
The significant increase in Ra Medical Systems' share price could lead to a short-term positive impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Aptevo Therapeutics shares fell 9.59% to $1.32.
The significant decrease in Aptevo Therapeutics' share price could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Bluejay Diagnostics shares fell 10.39% to $0.24.
The significant decrease in Bluejay Diagnostics' share price could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Infinity Pharmaceuticals shares fell 14.5% to $0.18 during Tuesday's pre-market session.
The significant decrease in Infinity Pharmaceuticals' share price could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Kintara Therapeutics stock fell 7.7% to $3.72.
The significant decrease in Kintara Therapeutics' share price could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Laboratory Corp shares decreased by 13.4% to $209.0.
The significant decrease in Laboratory Corp's share price could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Lipella Pharmaceuticals shares decreased by 8.88% to $1.95.
The significant decrease in Lipella Pharmaceuticals' share price could lead to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100